Sort by
Refine Your Search
-
Listed
-
Category
-
Country
-
Program
-
Field
-
hours/week. Interns will earn $17.50-$21.50/hour. This role is hybrid in Boston. Specific work hours will be determined by the supervisor. What you'll do Assist in the setup and operation of simulator
-
for the OPUS 28 call: https://ncn.gov.pl/sites/default/files/pliki/uchwaly-rady/2024/uchwala84_2024-zal1.pdf The candidate should: Know the physiology of the nervous system, molecular and cell biology
-
research (https://www.kcl.ac.uk/scms ). We study the fundamental molecular, cellular, and physiological processes that underly normal and abnormal cardiovascular and metabolic function and we drive
-
available in the Pan Hammarström Lab (https://ki.se/en/research/groups/pan-hammarstrom-lab ), which is part of the Division of Immunology under the Department of Medical Biochemistry and Biophysics
-
Department: Tomáš Bárta Research Group: Stem Cell Biology and Vision Research – Faculty of Medicine Deadline: 31 Jan 2026 Start date: April 2026 or upon agreement Job type: full-time Job field
-
to the development of large-scale bone tissue implants. Beyond a certain size, sufficient vascularization of the implant is essential to enable the formation of functional bone tissue and to reduce cell necrosis
-
Instituto de Investigação e Inovação em Saúde da Universidade do Porto (i3S) | Portugal | 25 days ago
regulation and lymphoma pathogenesis, has emerged as a promising candidate. We showed that PSGL-1 blockade with a monoclonal antibody (mAb) enhances T cell activation, alters the lymphoma immune
-
position within a Research Infrastructure? No Offer Description JOB REFERENCE: PA260302 Full-time academic position Faculty of Sciences Field: Animal cell Biology Start date: 01/09/2026 The University
-
the patient's electronic health record. Participate in professional development, simulation, and continuing education. Attend ECMO Team meetings and M&M conferences on a regular basis. Minimum Qualifications
-
tumour cells (CTCs), cancer cell free-mRNA and DNA from blood, offer a minimally invasive approach for early diagnosis and disease monitoring cancer progression and treatment response. However, the current